Use the outer-back portion, between shoulder and elbow, and avoid the inner arm
Retrospective studies by Jamal et al
News provided by Eli Lilly and Company May 13, 2022, 17:54 ET Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials While not indicated for weight loss, Mounjaro led to significantly greater weight reductions versus comparators in a key secondary endpoint Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is expected to be available in the U.S
Some people report feeling unusually warm or notice slight increases in heart rate, which aligns with the glucagon receptor activation increasing energy expenditure
Ozempic se aplica mediante una inyeccin subcutnea (debajo de la piel) una vez por semana, siempre el mismo da de la semana, en abdomen, muslo o parte superior del brazo
Zepbound and Mounjaro use the same active ingredient tirzepatide, similar to semaglutide, FDA-approved for people with obesity or overweight accompanied by diet and fitness